Literature DB >> 31759925

Young adults and metachronous neoplasia: risks for future advanced adenomas and large serrated polyps compared with older adults.

Joseph C Anderson1, Christina M Robinson2, Lynn F Butterly2.   

Abstract

BACKGROUND AND AIMS: Recent increases in colorectal cancer (CRC) incidence in adults younger than 50 years of age have led to more colonoscopies in this age group. As a result, there may be an increasing number of adults <50 years old with polyps detected. There is concern that younger adults may require closer follow-up. Our goal was to use data from the New Hampshire Colonoscopy Registry (NHCR) to examine the risk for metachronous advanced adenomas (AAs) and large (>1 cm) serrated polyps in younger versus older adults who return for a follow-up colonoscopy.
METHODS: Our cohort consisted of NHCR participants with at least 1 polyp on index examination and a follow-up colonoscopy at least 1 year after the index examination. Outcomes were the risks for metachronous AAs (adenomas ≥1 cm, with villous elements or high-grade dysplasia, or CRC) and large (≥1 cm) serrated polyps. We present absolute risk and adjusted risks from a logistic regression model stratified by age at index colonoscopy (<40, 40-49, 50-59, and 60+ [reference]). Covariates included index findings, endoscopist adenoma detection rates, sex, smoking, body mass index, follow-up time (months), bowel preparation quality, and family history of CRC.
RESULTS: In our sample of 12,380 adults, absolute risk for metachronous AA was lower for younger patients than for patients aged ≥60. After adjusting for covariates, when comparing with the 60+ group (reference), the lowest risk was observed in those younger than 40 years (odds ratio, .19; 95% confidence interval, .05-.80). Of note, similar risks were observed in the 40 to 49 age group (odds ratio, .61; 95% confidence interval, .41-.92) and 50 to 59 age group (odds ratio, .71; 95% confidence interval, .58-.86). The risk for large metachronous serrated polyps was not associated with age.
CONCLUSIONS: Younger adults aged <40 with index adenomas had a lower risk for metachronous AAs than those aged ≥60. The 40- to 49-year age group was found to have metachronous risk similar to the 50- to 59-year age group, with both less than the ≥60 age group. These data suggest that current surveillance interval guidelines for patients aged ≥50 years may appropriately be used with younger adults. Published by Elsevier Inc.

Entities:  

Year:  2019        PMID: 31759925      PMCID: PMC7039748          DOI: 10.1016/j.gie.2019.11.023

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  28 in total

1.  Findings of diagnostic colonoscopy in young adults versus findings of screening colonoscopy in patients aged 50 to 54 years: a comparative study stratified by symptom category.

Authors:  Jae-Myung Cha; Richard A Kozarek; Danielle La Selva; Michael Gluck; Andrew Ross; Michael Chiorean; Johannes Koch; Otto S Lin
Journal:  Gastrointest Endosc       Date:  2015-04-02       Impact factor: 9.427

2.  Are temporal trends in colonoscopy among young adults concordant with colorectal cancer incidence?

Authors:  Stacey A Fedewa; Rebecca L Siegel; Ahmedin Jemal
Journal:  J Med Screen       Date:  2019-07-11       Impact factor: 2.136

3.  Colorectal Cancer Mortality Rates in Adults Aged 20 to 54 Years in the United States, 1970-2014.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  JAMA       Date:  2017-08-08       Impact factor: 56.272

4.  Is 35 the new 50? Challenges in determining colonoscopy surveillance recommendations for young patients with incidentally detected adenomas.

Authors:  Karla Cameron; Alan Moss
Journal:  Gastrointest Endosc       Date:  2018-11       Impact factor: 9.427

5.  Risk of Metachronous High-Risk Adenomas and Large Serrated Polyps in Individuals With Serrated Polyps on Index Colonoscopy: Data From the New Hampshire Colonoscopy Registry.

Authors:  Joseph C Anderson; Lynn F Butterly; Christina M Robinson; Julia E Weiss; Christopher Amos; Amitabh Srivastava
Journal:  Gastroenterology       Date:  2017-09-18       Impact factor: 22.682

6.  Metachronous colon polyps in younger versus older adults: a case-control study.

Authors:  Sajan Jiv Singh Nagpal; Dhruvika Mukhija; Madhusudhan Sanaka; Rocio Lopez; Carol A Burke
Journal:  Gastrointest Endosc       Date:  2017-05-23       Impact factor: 9.427

7.  Prevalence of colorectal neoplasia in smokers.

Authors:  Joseph C Anderson; Rajeev Attam; Zvi Alpern; Catherine R Messina; Patricia Hubbard; Roger Grimson; Peter F Ells; Douglas L Brand
Journal:  Am J Gastroenterol       Date:  2003-12       Impact factor: 10.864

8.  Young patients with sporadic colorectal adenomas: current endoscopic surveillance practices and outcomes.

Authors:  Jae Myung Cha; Danielle La Selva; Richard A Kozarek; Michael Gluck; Andrew Ross; Otto S Lin
Journal:  Gastrointest Endosc       Date:  2018-06-13       Impact factor: 9.427

9.  Improving the quality of colorectal cancer screening: assessment of familial risk.

Authors:  Lynn F Butterly; Martha Goodrich; Tracy Onega; Mary Ann Greene; Amitabh Srivastava; Randall Burt; Allen Dietrich
Journal:  Dig Dis Sci       Date:  2010-03       Impact factor: 3.199

10.  Body mass index: a marker for significant colorectal neoplasia in a screening population.

Authors:  Joseph C Anderson; Catherine R Messina; Fouad Dakhllalah; Biju Abraham; Zvi Alpern; Carol Martin; Patricia M Hubbard; Roger Grimson; Robert D Shaw
Journal:  J Clin Gastroenterol       Date:  2007-03       Impact factor: 3.062

View more
  2 in total

1.  Yield of Surveillance Colonoscopy in Older Adults with a History of Polyps: A Systematic Review and Meta-Analysis.

Authors:  Gregory J Williams; Sage T Hellerstedt; Paige N Scudder; Audrey H Calderwood
Journal:  Dig Dis Sci       Date:  2021-08-18       Impact factor: 3.487

2.  Risk stratification for advanced colorectal neoplasia based on the findings of the index and first surveillance colonoscopies.

Authors:  Munenori Honda; Hideaki Naoe; Ryosuke Gushima; Hideaki Miyamoto; Masakuni Tateyama; Kouichi Sakurai; Yasushi Oda; Yoshitaka Murakami; Yasuhito Tanaka
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.